Top Menu

Author Archive | Carly Helfand

How Can Pharma Help More Chronically Ill Patients? Engage Their Caregivers Directly, Survey Says

Pharma companies don’t typically market directly to caregivers of patients with chronic conditions. But they might want to consider it, new data from Phreesia Life Sciences suggests. More than half of chronically ill patients rely on their caregivers to make healthcare decisions for them, according to a nationwide survey of more than 2,000 caregivers conducted […]

Continue Reading 0
Source: Mohamed_Hassan via Pixabay

New CGRP Drugs are Flooding the Migraine Market—But They’re Not Making a Splash with Patients

Since May 2018, several calcitonin gene-related peptide (CGRP) inhibitors have entered the migraine field, with no fewer than seven gaining U.S. Food & Drug Administration approval for acute migraine treatment and/or prevention. Thanks to this influx of new prescription therapies, the global migraine market is expanding, with some analysts expecting to see its value soar […]

Continue Reading 0